Engineered Biosynthesis of Alkyne-Tagged Polyketides by Type I PKSs
Polyketides produced by modular polyketide synthases (PKSs) are important small molecules widely used as drugs, pesticides, and biological probes. Tagging these polyketides with a clickable functionality enables the visualization, diversification, and mode of action study through bio-orthogonal chem...
Saved in:
Published in | iScience Vol. 23; no. 3; p. 100938 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
27.03.2020
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Polyketides produced by modular polyketide synthases (PKSs) are important small molecules widely used as drugs, pesticides, and biological probes. Tagging these polyketides with a clickable functionality enables the visualization, diversification, and mode of action study through bio-orthogonal chemistry. We report the de novo biosynthesis of alkyne-tagged polyketides by modular type I PKSs through starter unit engineering. Specifically, we use JamABC, a terminal alkyne biosynthetic machinery from the jamaicamide B biosynthetic pathway, in combination with representative modular PKSs. We demonstrate that JamABC works as a trans loading system for engineered type I PKSs to produce alkyne-tagged polyketides. In addition, the production efficiency can be improved by enhancing the interactions between the carrier protein (JamC) and PKSs using docking domains and site-directed mutagenesis of JamC. This work thus provides engineering guidelines and strategies that are applicable to additional modular type I PKSs to produce targeted alkyne-tagged metabolites for chemical and biological applications.
[Display omitted]
•Alkyne-tagged polyketides are de novo biosynthesized using type I PKSs•Docking domains and ACP mutagenesis improve alkyne starter unit translocation•Docking domains, but not ACP mutagenesis, perturb alkyne biosynthetic machinery
Chemical Engineering; Biochemical Engineering; Metabolic Engineering; Biotechnology |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 USDOE Office of Science (SC) Alfred P. Sloan Foundation AC02-05CH11231 National Institutes of Health (NIH) Chan Zuckerberg Biohub Lead Contact |
ISSN: | 2589-0042 2589-0042 |
DOI: | 10.1016/j.isci.2020.100938 |